None listed
Conditions
Interventions
None listed
Sponsors
Samsung Changwon Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients who underwent elective Cesarean section from January 2019 to August 2021 and were prescribed intravenous patient-controlled analgesia.
Exclusion criteria
Exclusion criteria: 1. If clinical informations are insufficient in the patient's medical records 2. If the intravenous patient-controlled analgesia infusion device is broken and discarded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome aims to find out if there is a significant difference in intravenous patient-controlled analgesia discard and additional prescriptions, side effects, and prescription of analgesics in the ward as intravenous patient-controlled analgesia regimen is changed in patients undergoing elective Cesarean section. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome aims to find out if there is a significant difference in intravenous patient-controlled analgesia discard and additional prescriptions, side effects, and prescription of analgesics in the ward in patients with wound infiltration with local anesthetics after Cesarean section. | — |
Countries
Korea, Republic of
Contacts
Public ContactJeong won Park
Masan Samsung Medical Center
Outcome results
None listed